Patents by Inventor Stephanie J. Lathrop

Stephanie J. Lathrop has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods For Treating Bleeding
    Publication number: 20080188400
    Abstract: Methods for the treatment of various bleeding disorders using variants of human Factor VII (hFVII) or activated FVII (FVIIa) having an altered activity compared to 5 recombinant FVIIa with the native human sequence.
    Type: Application
    Filed: April 25, 2006
    Publication date: August 7, 2008
    Inventors: Mads Ropke, Stephanie J. Lathrop
  • Methods and compositions for developing spore display systems for medicinal and industrial applications
    Publication number: 20030165538
    Abstract: Compositions and methods for utilizing spore systems for medicinal and industrial protein applications are provided. Compositions comprise spores that produce and/or display carbohydrates, proteins, peptides, and nucleic acids of interest. Such spores are useful as therapeutic or prophylactic agents or vaccines against a broad spectrum of immunogens and bacterial and viral pathogens. Additionally, spore systems are useful in production, packaging, delivery, and presentation of polypeptides and/or nucleic acids for industrial catalysts, medical applications, and diagnostic applications.
    Type: Application
    Filed: June 26, 2001
    Publication date: September 4, 2003
    Applicant: Maxygen Incorporated
    Inventors: Stanley Goldman, Stephanie J. Lathrop, Pascal F. Longchamp, Robert G. Whalen
  • Methods and compositions for developing spore display systems for medicinal and industrial applications
    Publication number: 20020150594
    Abstract: Compositions and methods for utilizing spore systems for medicinal and industrial protein applications are provided. Compositions comprise spores that produce and/or display carbohydrates, proteins, peptides, and nucleic acids of interest. Such spores are useful as therapeutic or prophylactic agents or vaccines against a broad spectrum of immunogens and bacterial and viral pathogens. Additionally, spore systems are useful in production, packaging, delivery, and presentation of polypeptides and/or nucleic acids for industrial catalysts, medical applications, and diagnostic applications.
    Type: Application
    Filed: December 19, 2001
    Publication date: October 17, 2002
    Applicant: Maxygen, Inc.
    Inventors: Stanley Goldman, Stephanie J. Lathrop, Pascal F. Longchamp, Robert G. Whalen